MX2017003360A - Composicion para la prevencion y/o tratamiento de sintomas de alergia. - Google Patents
Composicion para la prevencion y/o tratamiento de sintomas de alergia.Info
- Publication number
- MX2017003360A MX2017003360A MX2017003360A MX2017003360A MX2017003360A MX 2017003360 A MX2017003360 A MX 2017003360A MX 2017003360 A MX2017003360 A MX 2017003360A MX 2017003360 A MX2017003360 A MX 2017003360A MX 2017003360 A MX2017003360 A MX 2017003360A
- Authority
- MX
- Mexico
- Prior art keywords
- composition
- prevention
- treatment
- symptoms
- allergy symptoms
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 208000024891 symptom Diseases 0.000 title abstract 5
- 206010020751 Hypersensitivity Diseases 0.000 title abstract 3
- 208000026935 allergic disease Diseases 0.000 title abstract 3
- 230000007815 allergy Effects 0.000 title abstract 3
- 230000002265 prevention Effects 0.000 title abstract 3
- DOUMFZQKYFQNTF-WUTVXBCWSA-N (R)-rosmarinic acid Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-WUTVXBCWSA-N 0.000 abstract 2
- 206010010744 Conjunctivitis allergic Diseases 0.000 abstract 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 abstract 2
- 206010039085 Rhinitis allergic Diseases 0.000 abstract 2
- 208000002205 allergic conjunctivitis Diseases 0.000 abstract 2
- 201000010105 allergic rhinitis Diseases 0.000 abstract 2
- 208000024998 atopic conjunctivitis Diseases 0.000 abstract 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 abstract 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 abstract 2
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 abstract 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 abstract 1
- 244000124853 Perilla frutescens Species 0.000 abstract 1
- 235000004348 Perilla frutescens Nutrition 0.000 abstract 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 abstract 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 abstract 1
- ZZAFFYPNLYCDEP-HNNXBMFYSA-N Rosmarinsaeure Natural products OC(=O)[C@H](Cc1cccc(O)c1O)OC(=O)C=Cc2ccc(O)c(O)c2 ZZAFFYPNLYCDEP-HNNXBMFYSA-N 0.000 abstract 1
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 abstract 1
- 235000008714 apigenin Nutrition 0.000 abstract 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 abstract 1
- 229940117893 apigenin Drugs 0.000 abstract 1
- 235000004883 caffeic acid Nutrition 0.000 abstract 1
- 229940074360 caffeic acid Drugs 0.000 abstract 1
- -1 catechina Chemical compound 0.000 abstract 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
- 235000001785 ferulic acid Nutrition 0.000 abstract 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 abstract 1
- 229940114124 ferulic acid Drugs 0.000 abstract 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 abstract 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 abstract 1
- 235000009498 luteolin Nutrition 0.000 abstract 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229960001285 quercetin Drugs 0.000 abstract 1
- 235000005875 quercetin Nutrition 0.000 abstract 1
- DOUMFZQKYFQNTF-MRXNPFEDSA-N rosemarinic acid Natural products C([C@H](C(=O)O)OC(=O)C=CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-MRXNPFEDSA-N 0.000 abstract 1
- TVHVQJFBWRLYOD-UHFFFAOYSA-N rosmarinic acid Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=Cc2ccc(O)c(O)c2)C=O TVHVQJFBWRLYOD-UHFFFAOYSA-N 0.000 abstract 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Emergency Medicine (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención se refiere a una composición farmacéutica o una composición de suplemento alimenticio y uso de los mismos en la prevención y/o tratamiento de síntomas de alergia, preferiblemente rinitis alérgica y/o síntomas de conjuntivitis alérgica. En particular, la composición de acuerdo con la invención comprende al menos un componente de liberación lenta que comprende quercetina y al menos un componente de liberación rápida que comprende un extracto de Perilla frutescens o un constituyente del mismo seleccionado de luteolina, ácido rosmarínico, apigenina, catequina, ácido ferúlico, ácido cafeico o mezclas de los mismos. La invención además comprende el uso de la composición en la prevención y/o tratamiento de síntomas de alergia, preferiblemente rinitis alérgica y/o síntomas de conjuntivitis alérgica.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI20141641 | 2014-09-22 | ||
| PCT/IB2015/057267 WO2016046728A1 (en) | 2014-09-22 | 2015-09-21 | Composition for the prevention and/or treatment of allergy symptoms |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2017003360A true MX2017003360A (es) | 2017-06-21 |
Family
ID=51799187
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017003360A MX2017003360A (es) | 2014-09-22 | 2015-09-21 | Composicion para la prevencion y/o tratamiento de sintomas de alergia. |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US10143715B2 (es) |
| EP (1) | EP3197556B1 (es) |
| CA (1) | CA2958174C (es) |
| DK (1) | DK3197556T3 (es) |
| ES (1) | ES2968372T3 (es) |
| FI (1) | FI3197556T3 (es) |
| HR (1) | HRP20240090T1 (es) |
| MX (1) | MX2017003360A (es) |
| PL (1) | PL3197556T3 (es) |
| PT (1) | PT3197556T (es) |
| RS (1) | RS65173B1 (es) |
| SI (1) | SI3197556T1 (es) |
| WO (1) | WO2016046728A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107660794A (zh) * | 2017-08-31 | 2018-02-06 | 王双亮 | 一种药食同源槐米的制备方法 |
| IT202100021659A1 (it) * | 2021-08-10 | 2023-02-10 | A&R Pharma Srl | Composizione topica e suo uso per il trattamento nasale della rinite |
| IT202200002108A1 (it) * | 2022-02-07 | 2023-08-07 | Indena Spa | Composizioni a base di quercetina per il trattamento e la prevenzione di affezioni oculari |
| US20230338274A1 (en) * | 2022-04-22 | 2023-10-26 | Dermacisen, S.A. | Food supplement for hair care and hair loss prevention. |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001114686A (ja) | 1999-10-15 | 2001-04-24 | Sunstar Inc | Ｔｈ２サイトカイン発現抑制剤 |
| IT1315252B1 (it) | 1999-10-21 | 2003-02-03 | Truffini & Regge Farmaceutici | Compresse gastroresistenti ad uso alimentare o dietetico ottenutemediante grassi miscelati alla massa |
| US20080070875A1 (en) * | 2006-09-11 | 2008-03-20 | Majewski George P | Acne treatment compositions and methods of use |
| IT1393841B1 (it) | 2009-04-30 | 2012-05-11 | Giuliani Spa | Composizione farmaceutica o dermatologica o nutrizionale o cosmetica per combattere l'azione di immunosoppressione provocata sulla pelle da agenti aggressivi |
| AU2010314956A1 (en) | 2009-11-06 | 2012-04-12 | Alcon Research, Ltd. | Nutritional supplements for relief of dry eye |
-
2015
- 2015-09-21 PL PL15791737.8T patent/PL3197556T3/pl unknown
- 2015-09-21 CA CA2958174A patent/CA2958174C/en active Active
- 2015-09-21 HR HRP20240090TT patent/HRP20240090T1/hr unknown
- 2015-09-21 ES ES15791737T patent/ES2968372T3/es active Active
- 2015-09-21 MX MX2017003360A patent/MX2017003360A/es unknown
- 2015-09-21 WO PCT/IB2015/057267 patent/WO2016046728A1/en active Application Filing
- 2015-09-21 RS RS20240050A patent/RS65173B1/sr unknown
- 2015-09-21 PT PT157917378T patent/PT3197556T/pt unknown
- 2015-09-21 EP EP15791737.8A patent/EP3197556B1/en active Active
- 2015-09-21 SI SI201531984T patent/SI3197556T1/sl unknown
- 2015-09-21 DK DK15791737.8T patent/DK3197556T3/da active
- 2015-09-21 US US15/504,117 patent/US10143715B2/en active Active
- 2015-09-21 FI FIEP15791737.8T patent/FI3197556T3/fi active
-
2018
- 2018-06-26 US US16/018,381 patent/US10238707B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| SI3197556T1 (sl) | 2024-03-29 |
| US10143715B2 (en) | 2018-12-04 |
| US20170258864A1 (en) | 2017-09-14 |
| EP3197556B1 (en) | 2023-11-01 |
| CA2958174C (en) | 2023-08-15 |
| US20180296621A1 (en) | 2018-10-18 |
| RS65173B1 (sr) | 2024-03-29 |
| WO2016046728A1 (en) | 2016-03-31 |
| ES2968372T3 (es) | 2024-05-09 |
| PT3197556T (pt) | 2024-01-16 |
| FI3197556T3 (fi) | 2024-01-19 |
| HRP20240090T1 (hr) | 2024-04-26 |
| CA2958174A1 (en) | 2016-03-31 |
| PL3197556T3 (pl) | 2024-04-15 |
| US10238707B2 (en) | 2019-03-26 |
| DK3197556T3 (da) | 2024-01-22 |
| EP3197556A1 (en) | 2017-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL256085B (en) | A substituted derivative of cholanoic acid, a pharmaceutical composition comprising it and the substituted derivative for use in treatment | |
| MX2017009532A (es) | Uso de acidos grasos de cadena corta en prevencion de cancer. | |
| HUE036224T2 (hu) | C1-gátló készítmények örökletes angioödéma megelõzésében és kezelésében történõ alkalmazásra | |
| HK1217285A1 (zh) | 用於預防或治療絕經期症狀的、包含作為活性成分的含有香豆雌酚的大豆提取物的組合物 | |
| EP3102220C0 (en) | SYNERGIC FOOD SUPPLEMENT COMPOSITIONS FOR THE PREVENTION, TREATMENT OR REGULATION OF INFLAMMATORY DISORDERS | |
| IL284242A (en) | Gingerpine lysine suppressants, preparations containing them and their uses | |
| IL261982A (en) | A prophylactic and therapeutic preparation based on peroxaphthalate, especially a pharmaceutical preparation | |
| IL266441B (en) | Synergistic herbal compositions with prebiotic properties for the treatment of acne | |
| IL251351B (en) | Preparations for use in the treatment and prevention of surgical infections | |
| PH12016501989A1 (en) | Tea creamer compositions and uses thereof | |
| PH12017500348B1 (en) | Tetrahydroquinoline derivatives as bromodomain inhibitors | |
| MX2017003360A (es) | Composicion para la prevencion y/o tratamiento de sintomas de alergia. | |
| EP3413904A4 (en) | PLANT-BASED COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF PLANT INFECTIONS OR UNGALEAL INFECTIONS | |
| IN2014CH00840A (es) | ||
| IL248773B (en) | History -6,1-Naphthyridine-5,4-Dione and pharmaceutical preparations containing them | |
| TR201908639T4 (tr) | Dejeneratif göz bozukluklarının önlenmesi ve veya tedavisine yönelik safran bazlı bileşimler. | |
| MY177827A (en) | Combination of valerian root extract and lavender oil for use in the treatment of sleep disorders | |
| EP3144005A4 (en) | Composition for preventing and treating male infertility, containing mixed herbal extract as active ingredient and use thereof | |
| IL280389A (en) | Bile acid receptor modulators conjugated to G.1 protein and methods of using them | |
| GB201403899D0 (en) | Synergistic composition comprising quercetin and polyphosphate for treatment of bone disorders | |
| RS62116B1 (sr) | Kompozicije koje sadrže geraniol i suvi đumbir za upotrebu u lečenju sindroma iritabilnog kolona | |
| BR112016014617A2 (pt) | Variante do fator xa (fxa) e usos da referida variante | |
| PH12019500464A1 (en) | An oxazine derivative for use in the treatment or prevention of cerebral amyloid angiopathy | |
| IL247616B (en) | Centrally acting acetylcholinesterase inhibitors for the prevention/or treatment of chemically induced neurodegenerative diseases and their symptoms, and corresponding compositions, uses, methods and kit | |
| EP3104940A4 (en) | Compositions and methods for the prevention and/or treatment of schistosomiasis |